相似文献/References:
[1]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[2]沈强 张学东.糖尿病黄斑水肿的发病机制及治疗进展[J].眼科新进展,2012,32(2):000.
[3]李疏凤,王帅,李婷婷,等.多重酪氨酸激酶受体抑制剂decorin对高糖低氧条件下血-视网膜内屏障的保护作用及机制研究[J].眼科新进展,2017,37(6):501.[doi:10.13389/j.cnki.rao.2017.0127]
LI Shu-Feng,WANG Shuai,LI Ting-Ting,et al.Protective effects of decorin on blood-retinal barrier function under high-glucose plus hypoxia conditions[J].Recent Advances in Ophthalmology,2017,37(5):501.[doi:10.13389/j.cnki.rao.2017.0127]
[4]郑永征,谢茂松,刘光辉,等.阿那白滞素在治疗大鼠前节内眼模拟手术诱发的血-视网膜屏障破坏中的作用[J].眼科新进展,2020,40(1):016.[doi:10.13389/j.cnki.rao.2020.0004]
ZHENG Yongzheng,XIE Maosong,LIU Guanghui,et al.Role of Anakinra in alleviating blood retina barrier breakdown induced by anterior intraocular simulation operation in rats[J].Recent Advances in Ophthalmology,2020,40(5):016.[doi:10.13389/j.cnki.rao.2020.0004]
[5]唐磊,徐国彤,张敬法.褪黑素治疗糖尿病视网膜病变的研究进展[J].眼科新进展,2021,41(7):684.[doi:10.13389/j.cnki.rao.2021.0142]
TANG Lei,XU Guotong,ZHANG Jingfa.Progress of melatonin in the treatment of diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(5):684.[doi:10.13389/j.cnki.rao.2021.0142]
[6]刘自强,接传红,王建伟,等.糖尿病视网膜病变免疫机制的研究进展[J].眼科新进展,2022,42(2):150.[doi:10.13389/j.cnki.rao.2022.0031]
LIU Ziqiang,JIE Chuanhong,WANG Jianwei,et al.Research progress in immune mechanisms against diabetic retinopathy[J].Recent Advances in Ophthalmology,2022,42(5):150.[doi:10.13389/j.cnki.rao.2022.0031]